Document Type

Article

Language

eng

Format of Original

2 p.

Publication Date

2-2016

Publisher

American Society for Microbiology

Source Publication

Journal of Clinical Microbiology

Source ISSN

0095-1137

Abstract

Trichomonas vaginalis is the most common nonviral etiology of sexually transmitted infection (STI) worldwide. The OSOM Trichomonas rapid test (OSOM; Sekisui Diagnostics, San Diego, CA) is a rapid surrogate to microscopic analysis in symptomatic patients, but its performance in low-prevalence STI populations has been assessed on a limited basis in the literature. OSOM has widespread usage, as accreditation data from the College of American Pathologists report that over 300 participant laboratories utilize this assay on an annual basis. We sought to characterize the analytical and clinical performance of OSOM in a low-prevalence STI population on the basis of a commercial transcription-mediated amplification (TMA) reference.

Comments

Published version. Journal of Clinical Microbiology, Vol. 54, No. 2 (February 2016): 500-501. DOI. © American Society for Microbiology 2016. Used with permission.

Share

COinS